A synthetic peptide for use as a blocking control in assays to test for specificity of CYP3 A7 antibody, Alternative Names: CYP3A7 control peptide, CYP3A7 antibody Blocking Peptide, Anti-CYP3A7 Blocking Peptide, Cytochrome P450 Family 3 Subfamily A Polypeptide 7 Blocking Peptide, CP37 Blocking Peptide, P450-HFLA Blocking Peptide, CYP3A7, CYPA7-3, CYPA7 3, CYPA7-3 Blocking Peptide, CYPA7 3 Blocking Peptide
CYP3A7
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CYP3A7
(Cytochrome P450, Family 3, Subfamily A, Polypeptide 7 (CYP3A7))
Synonyme
CP37 Peptide, CYPIIIA7 Peptide, P450-HFLA Peptide, cytochrome P450, family 3, subfamily A, polypeptide 7 Peptide, cytochrome P450 family 3 subfamily A member 7 Peptide, CYP3A7 Peptide
Hintergrund
CYP3A7 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. The enzyme also metabolizes some drugs such as aflatoxin B1.